Navigation Links
Molecular Imaging of Colorado Joins Integrated Diagnostic Centers’ Denver Radiology Network
Date:5/16/2016

Molecular Imaging of Colorado (MIC), the wholly-owned subsidiary of statistically measured brain diagnostics company CereScan, is proud to announce it has joined Integrated Diagnostic Centers’ (IDC) metro Denver radiology network. The IDC relationship enables MIC to accept Physician Health Partners (PHP) patients and supports PHP’s commitment to providing superior cost-effective healthcare options.

“The opportunity will allow Physician Health Partners to continue its mission of coordinating high-quality, value-based care,” said John Allen, CEO of Integrated Diagnostic Centers. “MIC and PHP’s commitment to offering better diagnostic imaging solutions and care with substantial savings for patients will ensure a successful partnership for years to come.”

PHP collaborates with more than 300 primary care providers, both physicians and mid-level providers, and hundreds of specialists in the Denver metro area. The organization supports physicians by providing innovative tools and programs to help drive quality outcomes and more cost-effective healthcare to patients.

*****

“We look forward to exceeding the service expectations and values set forth by Physician Health Partners,” said Sean Strauss, Vice President of Clinical Services for Molecular Imaging of Colorado and CereScan. “We believe our superior service and cost-effective nuclear medicine solutions will produce outstanding results for PHP providers and their patients.”

With its exceptional customer service, fast turnaround and modern facility, MIC is one of the premier nuclear medicine facilities in Denver. Additionally, PHP patients will pay roughly 30 to 60 percent less for PET/CT scans at MIC when compared to other imaging centers in the region.

Molecular Imaging of Colorado is based in Littleton, Colorado, and is a wholly-owned subsidiary of CereScan. MIC provides PET/CT imaging services to the patients of Oncologists, Pulmonologists, and Urologists and any others who may need diagnostic imaging. To schedule an appointment or for more information, please call 303-954-4957 or visit http://www.MICimaging.net.

*****

CereScan is the nation’s leader in providing statistically measured brain diagnostics based on a new generation of imaging software, PET/CT (Positron Emission Tomography/Computed Tomography) and SPECT (Single Photon Emission Computed Tomography) neuroimaging technologies. Referring and treating medical experts can rely on CereScan to offer differentiated diagnoses on a wide array of brain-based disorders including:

  •     ADD/ADHD
  •     Alzheimer’s Disease
  •     Anxiety Disorder
  •     Bipolar Disorder
  •     Dementia
  •     Mild Cognitive Impairment
  •     Obsessive Compulsive Disorder
  •     Parkinson’s Disease
  •     PTSD
  •     Stroke
  •     Traumatic Brain Injury
  •     Toxic Brain Injury

About Integrated Diagnostic Centers
Headquartered in Houston, Texas, Integrated Diagnostic Centers (IDC) is a venture capital-backed private company, with a history of physician practice and ancillary service management. In 1999, it transformed its business into IDC, entering the diagnostic imaging arena. In 2007, IDC expanded its diagnostic imaging operations to a national presence through its acquisition of a national network of diagnostic imaging providers, The National Radiology Network (TNRN). Today the IDC/TNRN network includes nearly 2,000 diagnostic imaging facilities nationwide.

About Physician Health Partners
Physician Health Partners (PHP) is an integrated team of physicians and healthcare professionals committed to supporting effective patient care throughout the healthcare continuum. Founded in 1996 as a management services organization, the company believes physicians and other providers have the capability and responsibility to drive high quality, cost-effective healthcare for patients. PHP provides support to primary care physicians in improving clinical outcomes for the benefit of the patient. By improving clinical outcomes, enhancing provider performance and developing practice efficiencies, patients' health status is improved and overall healthcare costs are reduced.

About CereScan
CereScan combines state-of-the-art SPECT and PET/CT brain imaging technologies with a patient centered model of care to provide the highest level of neurodiagnostics anywhere. Using quantitative functional brain imaging, advanced imaging software, and an extensive library of clinical data, the CereScan medical team provides physicians with unmatched objective diagnostic information. CereScan helps patients and their physicians better understand the neurological basis of their conditions. In a variety of legal settings, CereScan provides objective evidence to attorneys and their clients regarding traumatic and toxic brain injuries. For researchers, CereScan provides independent pre- and post-treatment measures of organic changes in the brain along with measures of symptoms related to the brain disorder of interest. For more information, please call (866) 722-4806 or visit http://www.CereScan.com.

Read the full story at http://www.prweb.com/releases/2016/05/prweb13415055.htm.


'/>"/>
Source: PRWeb
Copyright©2016 Vocus, Inc.
All rights reserved


Related biology technology :

1. European Molecular Diagnostic Market for Group A Streptococcus (GAS) Nucleic Acid (NA) Test Products Projected to Reach US$ 22.3 Mn in 2023: TMR
2. Caris Life Sciences to Present Molecular Insights Informing Treatment Strategies at the 2016 Society of Gynecologic Oncology Annual Meeting
3. Biocept to Present at Molecular Medicine Tri-Con 2016
4. Atomic Force Microscope Leader Park Systems Presents SupramolecularChemistry Webinar as Part of a Nanotechnology Series
5. Europe Molecular Diagnostics Market to Reach US$4.2 bn by 2023, Adoption of Next Generation Sequencing Technologies Rapidly Rise: Transparency Market Research
6. BioGenex Completes Construction of a State-of-the-Art Center for Cancer Diagnostics and Molecular Pathology Innovation in Hyderabad, India
7. ZeptoMetrix™ (ZMC) to Release NATtrol™ Inactivated Zika Virus for the Development of Molecular Diagnostic Assays and Ongoing Clinical Laboratory Quality Control
8. Report: Molecular Tissue and Cell-Based Testing a 2.5 Billion-Dollar Market
9. CereScan and Molecular Imaging of Colorado Add TRICARE to Approved Insurers
10. Caris Life Sciences Research Yields New Molecular Insights into Rare Breast Cancers
11. Global Molecular Diagnostics Market 2016: Latest Instrumentation and Strategic Profiles of Leading Suppliers - Abbott, Beckman Coulter, BD, Bio-Rad, Gen-Probe, Tecan & Trinity Biotech
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2017)... ... , ... Frederick Innovative Technology Center, Inc. (FITCI), a business ... start-ups, is hosting “Celebration Friday” (a festive gathering highlighting client success stories) and ... networking at 3:30 p.m. at FITCI’s 4539 Metropolitan Court location, off English Muffin ...
(Date:4/20/2017)... Linda, Ca (PRWEB) , ... April 20, 2017 ... ... University Virtual Event , this new webinar will explore challenging patient cases when ... admitted to the hospital, there may be a need for bridging parental anticoagulation ...
(Date:4/20/2017)... April 20, 2017  Eli Lilly and Company (NYSE: ... evaluating galcanezumab for the prevention of migraine at the ... take place April 22-28, 2017, in Boston ... abstracts at AAN, including safety and patient outcomes data ... with a reduction in monthly migraine headache days among ...
(Date:4/20/2017)... ... April 20, 2017 , ... ... scientific and clinical research community’s growing body of knowledge during its Eighth ... Gracie Theatre and the adjacent Darling Atrium. During the event, undergraduates, graduate students, ...
Breaking Biology Technology:
(Date:4/13/2017)... India , April 13, 2017 According to ... Proofing, Identity Authentication, Identity Analytics, Identity Administration, and Authorization), Service, Authentication Type, ... MarketsandMarkets™, the IAM Market is expected to grow from USD 14.30 Billion ... Growth Rate (CAGR) of 17.3%. ... MarketsandMarkets ...
(Date:4/11/2017)... Research and Markets has announced the addition of the "Global ... ... at a CAGR of 30.37% during the period 2017-2021. ... based on an in-depth market analysis with inputs from industry experts. ... the coming years. The report also includes a discussion of the ...
(Date:4/11/2017)... NXT-ID, Inc. (NASDAQ:   NXTD ) ("NXT-ID" or ... independent Directors Mr. Robin D. Richards and Mr. ... the company,s corporate governance and expertise. ... Gino Pereira , Chief Executive Officer said," ... and benefiting from their considerable expertise as we move forward ...
Breaking Biology News(10 mins):